Yellow fever study : expansion of patient categories
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
After positive results, the study continues with the inclusion of new patient categories.
The study with adult participants has been completed and the results confirm that for the four WHO prequalified vaccines, injecting only 1/5th of the dose produces a satisfactory immune response comparable to that produced by a standard dose. Following these results, the study continued with the inclusion of a more fragile population, namely HIV+ adults at the Kilifi site, Kenya and children over 5 years of age at the Mbarara site, Uganda. In 250 HIV+ adults and 420 children have been recruited and are currently completing their follow-up.
For several days, Médecins Sans Frontières and the MSF Foundation have been the target of an online smear campaign.Keywords associated with our organizations have been misused in several ...
Elizabeth Braga, a physiotherapist with MSF Foundation and a specialist in women’s health, recently visited northwestern Yemen. In collaboration with MSF teams, she explored the need for ...
The MSF Foundation and its partners are launching clinical studies for a new rapid diagnostic test (RDT) for measles. The goal is to provide a simple, reliable tool that can be used direc...
